Insights

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Symon Cotton, Head of Life Sciences at Cambridge Consultants, attended this year’s Society for Laboratory Automation and Screening conference, SLAS2021. Even in virtual form, the speakers dazzled with fresh and exciting ideas for the future of patient treatments.

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

Now you’ve got a talented team together, surely it’s time to push on to design and build your device? Not quite. In the latest in his series of articles, our VP Surgical Robotics & Advanced Surgical Systems Andrew Savarese explains the crucial importance of system architecture, the vital blueprint for project efficiency… 

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

After a tough year, C-suite executives of robotic start-ups are impatient for rapid progress. Andrew Savarese, VP Surgical Robotics & Advanced Surgical Systems, advocates a strategic, determined, thoughtful approach. Ultimately, he says, the team you assemble will determine your success…

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The next step in the fight against coronavirus looks set to be mass screening of whole cities and towns. Symon Cotton, Head of Life Sciences at Cambridge Consultants, believes that so-called multipool screening could make all the difference to the success of this approach during the current second wave of the virus.

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

In September the UK government announced Operation Moonshot – to deliver the mass screening of 10 million samples for COVID-19 every day. Andrew Goulter takes a pragmatic look at five key areas of focus if we are to increase screening efficiency and capacity.